Rabi Hanna: Gene Therapy Is Transforming Sickle Cell Disease
Rabi Hanna, Chairman, Department of Pediatric hematology-oncology and BMT at Cleveland Clinic Children’s at Cleveland Clinic, shared a post on LinkedIn:
“Today, on World Sickle Cell Day, I had the distinct honor of speaking at the Dutch Sickle Cell event in Amsterdam.
A special thank you to Erfan Nur for the invitation and the opportunity to join this critical conversation. It is a privilege to present an update on the rapidly evolving landscape of sickle cell gene therapy
While the scientific advancements we are seeing are groundbreaking, our work is far from finished.
The true measure of our success will be ensuring that these potentially curative treatments are accessible to everyone who needs them, regardless of geography or socioeconomic status.
Thank you to the Dutch SCD community for hosting such an inspiring event. Let’s continue pushing the boundaries of science while fighting for equitable care.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering